Justin Anslow

• Represented the underwriters in the $100 million follow-on offering by ImmunityBio
• Represented Sam Altman and affiliated entities in connection with the IPO of Reddit
• Represented Dynatrace in connection with the sale of $500 million of shares by selling stockholders
• Represented the underwriters in connection with the $237 million follow-on offering by selling stockholders of KnowBe4
• Represented Toast in its $1 billion IPO
• Represented GAN Limited in its IPO and follow-on offering of $165 million*
• Represented Tiziana Life Sciences in its follow-on offering of $60 million of its American depositary shares*
• Represented Cardiff Oncology in its follow-on offering of $100 million*
• Represented BioXcel Therapeutics in its $60 million IPO*
• Represented Aridis Pharmaceuticals in its $35 million IPO*
• Represented multiple SPACs in their IPOs including Goal Acquisitions Corp, Hennessy Capital Acquisition Corp. II and Global Partner Acquisition Corp.*

*Denotes experience prior to joining Goodwin.

• Representing BridgeBio Oncology Therapeutics in its proposed business combination with Helix Acquisition Corp. II
• Represented Frazier Life Sciences Acquisition Corp. in its business combination with NewAmsterdam Pharma Holding B.V.
• Represented Carbon Revolution in its business combination with Twin Ridge Capital Acquisition Corp.
• Represented Arrowroot Capital Acquisition Corp. in its business combination with iLearningEngines
• Represented Circle Internet Financial in its proposed business combination with Concord Acquisition Corp. 
• Represented Forge Global in its business combination with Motive Capital Corp.
• Represented the existing stockholders of Zapata AI, Wag!, Aurora Innovation and Vacasa in connection with the respective de-SPAC transactions of each company

• Represented the initial purchasers in the $460 million convertible senior notes offering by Box
• Represented the initial purchasers in the $300 million convertible senior notes offering by Rapid7
• Represented Cano Health in its offering of $300 million of senior notes 
• Represented LKQ Corp. in its offering of €1 billion of senior notes*
• Represented LendingTree in its offering of $300 million of convertible senior notes*

*Denotes experience prior to joining Goodwin.

• Represented RA Capital as the lead investor in the $240 million PIPE of Cidara Therapeutics
• Represented Greenlight BioSciences in its $110 million PIPE transaction
• Represented Vivo Capital as the lead investor in the PIPE financings of Delcath Systems, Gracell BioTechnologies and Unicycive Therapeutics
• Represented RA Capital as the lead investor in the $130 million PIPE of SAB Biotherapeutics

• Represented eMagin in its sale to Samsung Display Co.
• Represented Markforged in its sale to Nano Dimension Ltd
• Represented Greenlight BioSciences in its sale to Fall Line Capital
• Represented the Forbes Family in connection with multiple proposed sales of Forbes Global Media Holdings 
• Represented Innovate BioPharma in its merger with RDD Pharma*

*Denotes experience prior to joining Goodwin.

• Represented issuers and investment banks in multiple At-the-Market offerings 
• Represented Nerdy in its consent solicitation and exchange of outstanding warrants
• Represented WisdomTree in a strategic transaction and issuance of preferred stock
• Represented Cano Health in its entering into a $150 million term loan
• Represented LunaDNA in a first-of-its-kind Regulation A offering involving the issuance of securities in exchange for individual contributions of personal medical, health and related data*

*Denotes experience prior to joining Goodwin.